Estech sees first patients in staged hybrid ablation study

The first three patients have been enrolled in the European HISTORIC-AF staged hybrid ablation study, Estech announced Monday afternoon. Ten centers will participate in the study, which is expected to enroll more than 100 persistent and long-standing persistent atrial fibrillation patients in Italy, Germany, the U.K., France and Poland. Estech release

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.